Mairs & Power Inc Medpace Holdings, Inc. Transaction History

Mairs & Power Inc

$9.43 Billion
Q1 2025

A detailed history of Mairs & Power Inc transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Mairs & Power Inc holds 32,433 shares of MEDP stock, worth $10 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares

32,433

Previous 32,408 0.08%

Holding current value

$10 Million

Previous $10.8 Million 8.21%

% of portfolio

0.1%

Previous 0.11%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$304.69 - $360.97 $7,617 - $9,024	25 Added 0.08%	32,433 $9.88 Million
Q4 2024 Feb 14, 2025	BUY	$308.93 - $363.58 $817,428 - $962,032	2,646 Added 8.89%	32,408 $10.8 Million
Q3 2024 Nov 14, 2024	BUY	$320.58 - $457.29 $305,512 - $435,797	953 Added 3.31%	29,762 $9.93 Million
Q2 2024 Aug 14, 2024	BUY	$372.0 - $424.34 $7,440 - $8,486	20 Added 0.07%	28,809 $11.9 Million
Q1 2024 May 15, 2024	SELL	$284.87 - $413.31 $683,688 - $991,944	-2,400 Reduced 7.7%	28,789 $11.6 Million
Q4 2023 Feb 14, 2024	SELL	$227.52 - $312.68 $1.34 Million - $1.85 Million	-5,902 Reduced 15.91%	31,189 $9.56 Million
Q3 2023 Nov 14, 2023	BUY	$233.98 - $281.67 $1,403 - $1,690	6 Added 0.02%	37,091 $8.98 Million
Q2 2023 Aug 14, 2023	BUY	$187.26 - $240.17 $306,170 - $392,677	1,635 Added 4.61%	37,085 $8.91 Million
Q1 2023 May 15, 2023	BUY	$174.31 - $239.52 $696,368 - $956,882	3,995 Added 12.7%	35,450 $6.67 Million
Q3 2022 Nov 14, 2022	BUY	$145.13 - $182.49 $4.57 Million - $5.74 Million	31,455 New	31,455 $4.94 Million

Others Institutions Holding MEDP

# of Institutions

626

Shares Held

26M

Call Options Held

46.4K

Put Options Held

80.8K

View Full List

About Medpace Holdings, Inc.

Ticker MEDP
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 31,099,900
Market Cap $9.62B
Description
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...

More about MEDP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mairs & Power Inc, based on Form 13F filings with the SEC.

News

Stay updated on Mairs & Power Inc with notifications on news.

Account